肿瘤|手术难彻底,传统治疗不理想,肿瘤性骨软化症有了新的治疗方法!( 二 )


参考文献:
[1] Minisola S, Peacock M, Fukumoto S, et al. Tumour-induced osteomalacia[J]. Nat Rev Dis Primers. 2017;3:17044.
[2] Econs MJ, Drezner MK. Tumor-induced osteomalacia--unveiling a new hormone[J]. N Engl J Med. 1994;330(23):1679-81.
[3] Feng J, Jiang Y, Wang O,et al. The diagnostic dilemma of tumor induced osteomalacia: a retrospective analysis of 144 cases[J]. Endocr J. 2017;64(7):675-683.
[4] Endo I, Fukumoto S, Ozono K, et al. Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment[J]. Endocr J. 2015;62(9):811-6.
[5] Jiang Y, Xia WB, Xing XP, et al. Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature[J]. J Bone Miner Res. 2012;27(9):1967-75.
[6] Folpe AL, Fanburg-Smith JC, Billings SD, et al. Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature[J]. Am J Surg Pathol. 2004;28(1):1-30.
[7] Shimada T, Mizutani S, Muto T, et al. Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia[J]. Proc Natl Acad Sci U S A. 2001;98(11):6500-5.
[8] Jan de Beur SM, Streeten EA, Civelek AC, et al. Localisation of mesenchymal tumours by somatostatin receptor imaging[J]. Lancet. 2002;359(9308):761-3.
[9] Caudell JJ, Ballo MT, Zagars GK, et al. Radiotherapy in the management of giant cell tumor of bone[J]. Int J Radiat Oncol Biol Phys. 2003;57(1):158-65.
[10] Hesse E, Rosenthal H, Bastian L. Radiofrequency ablation of a tumor causing oncogenic osteomalacia[J]. N Engl J Med. 2007;357(4):422-4.
[11] 倪晓琳,夏维波.肿瘤性骨软化症的致病机制及治疗方法[J].中华临床免疫和变态反应杂志,2020,13(6):547-555.
[12] CClunie GP, Fox PE, Stamp TC. Four cases of acquired hypophosphataemic ('oncogenic') osteomalacia. Problems of diagnosis, treatment and long-term management[J]. Rheumatology (Oxford). 2000;39(12):1415-21.
[13] Lamb, Y.N. Burosumab: First Global Approval[J]. Drugs.2018;78, 707–714.
[14] Jan de Beur SM, Miller PD, Weber TJ, et al. Burosumab for the Treatment of Tumor-Induced Osteomalacia[J]. J Bone Miner Res. 2020 Dec 18.
[15] Imanishi Y, Ito N, Rhee Y, et al. Interim Analysis of a Phase 2 Open-Label Trial Assessing Burosumab Efficacy and Safety in Patients With Tumor-Induced Osteomalacia[J]. J Bone Miner Res. 2021 Feb;36(2):262-270.
内容审核:梁思
内容策划:王茉陈静
图片来源:站酷海洛

推荐阅读